Determination of dose enhancement caused by AuNPs with Xoft<sup>®</sup> Axxent<sup>®</sup> Electronic (eBx™) and conventional brachytherapy: in vitro study

Elham Shahhoseini, Prabhakar Ramachandran, William R. Patterson, Moshi Geso

International Journal of Nanomedicine · 2018 · 24 citations · 15 references

DOIFull text

Open access

Abstract

The higher DE values obtained with eBx™ compared to <sup>192</sup>Ir brachytherapy can be attributed to the lower average energy of the former and being closer to the optimal energy for DE. This could potentially be utilized by medical practitioners and clinicians to achieve the same tumor control with a significantly lower dose from the eBx™ compared to the <sup>192</sup>Ir brachytherapy treatment, thus bringing huge benefits to the brachytherapy-treated patients.

References

15